“Estimating the Budget Impact of Innovative Pharmacological Treatments for Patients With Type 2 Diabetes Mellitus in Italy: The Case of Liraglutide (GLP-1). ”. Epidemiology, Biostatistics, and Public Health 12, no. 2 (May 10, 2022). Accessed July 28, 2026. https://test-ojs-unimi-it.archicoop.it/index.php/ebph/article/view/17832.